Bioviglance / Projects

3rd Health Programme (2014-2020)
Equal access for all patients to high quality cells for transplantation [SAVDON]
WMDA strives that patients worldwide have equal access to high quality cells for transplantation from donors whose rights and safety are protected. To achieve this the WMDA has implemented a strategic...
WMDA strives that patients worldwide have equal access to high quality cells for transplantation from donors whose rights and safety are protected. To achieve this the WMDA has implemented a strategic plan for the years 2018-2021.
As an organisation that exists to achieve the best for stem cell donors and transplant patients, the strategy has been co-created with affiliate organisations. The strategy aims to deliver impact in the following areas:
- Optimising ‘search, match and connect’
- Supporting global development
- Promoting donor care
- Ensuring quality

The WMDA aims to facilitate the best possible stem cell source for transplant patients, while the rights and safety of the donors are promoted and protected. This is achieved by:
- setting up a good infrastructure to facilitate communication
- developing education programmes to share best practices
- maintain a platform to report serious adveres events and reactions in as well donors as patients
- promote accreditation and standardisation through the accreditation programme



Start date: 01/01/2020 - End date: 31/12/2020

Call: Financial Contribution to the Functioning of Non-Governmental Bodies - Invitation to submit proposals for Specific Operating Grant Agreements (SGA)
Topic: Bioviglance